The increased osteoclastogenesis and enhanced bone resorption results in the release of tumor growth promoting factors (e.g., transforming growth factor-β (TGF-β)) from the resorbed bone matrix [3,4]. The gene discussed is TGFB1; the disease is neoplasm.